The present invention relates to derivatives of benzimidazoles of formula (I)as disclosed herein as well as pharmaceuticalcompositions comprising said derivatives. The derivates according to thepresent invention are serine/threonine and tyrosinekinase-inhibitors, particularly of PIM1-3-and DYRK1A-kinases and mayparticularly be used in the treatment of diseases linked tothese kinases, such as e.g. leukemias, lymphomas, solid tumors and autoimmunedisorders.